We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue

    In the 1990s, as prevention became a central strategy in the battle against cancer and the molecular genetics revolution uncovered the genetic basis...

    Hans FA Vasen, Marcia Irene Canto, Michael Goggins in Familial Cancer
    Article Open access 06 June 2024
  2. Association between inflammatory factors and melanoma: a bidirectional Mendelian randomization study

    Purpose

    This study performed a bidirectional Mendelian randomization (MR) analysis to elucidate the causal relationships of C-reactive protein and 41...

    Jiamin Lu, Yuqian Feng, ... Kai Zhang in Cancer Causes & Control
    Article 06 June 2024
  3. A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures

    Background

    We examined the patterns of breast reconstruction postmastectomy in breast cancer patients undergoing postmastectomy radiotherapy (PMRT)...

    Hyejo Ryu, Kyung Hwan Shin, ... Bum-Sup Jang in British Journal of Cancer
    Article Open access 05 June 2024
  4. Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines

    Background

    British Sarcoma Group guidelines for the management of GIST were initially informed by those published by the European Society of Clinical...

    Ian Judson, Robin L. Jones, ... Max Almond in British Journal of Cancer
    Article Open access 05 June 2024
  5. Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy?

    Background

    Tolerability and antitumour efficacy of chemotherapy and radiation therapy can vary largely according to their time of administration along...

    Abdoulaye Karaboué, Pasquale F. Innominato, ... Francis A. Lévi in British Journal of Cancer
    Article Open access 04 June 2024
  6. CD57 defines a novel cancer stem cell that drive invasion of diffuse pediatric-type high grade gliomas

    Background

    Diffuse invasion remains a primary cause of treatment failure in pediatric high-grade glioma (pHGG). Identifying cellular driver(s) of pHGG...

    Lin Qi, Yuchen Du, ... **ao-Nan Li in British Journal of Cancer
    Article 04 June 2024
  7. Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer

    Background

    Preoperative chemoradiotherapy (CRT) followed by surgery is the standard treatment for locally advanced rectal cancer (LARC). We reported...

    Yuichiro Tsukada, Hideaki Bando, ... Takayuki Yoshino in British Journal of Cancer
    Article 04 June 2024
  8. Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice

    Background

    The CanRisk tool, which operationalises the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) is...

    Olga Tsoulaki, Marc Tischkowitz, ... Helen Hanson in British Journal of Cancer
    Article Open access 04 June 2024
  9. Clinical landscape of macrophage-reprogramming cancer immunotherapies

    Tumour-associated macrophages (TAMs) sustain a tumour-supporting and immunosuppressive milieu and therefore aggravate cancer prognosis. To modify TAM...

    Jenna H. Rannikko, Maija Hollmén in British Journal of Cancer
    Article Open access 03 June 2024
  10. Identifying patients with undiagnosed small intestinal neuroendocrine tumours in primary care using statistical and machine learning: model development and validation study

    Background

    Neuroendocrine tumours (NETs) are increasing in incidence, often diagnosed at advanced stages, and individuals may experience years of...

    Ash Kieran Clift, Hadley Mahon, ... Mohid S. Khan in British Journal of Cancer
    Article Open access 03 June 2024
  11. Tracing household transmission of SARS-CoV-2 in New Zealand using genomics

    By early 2022, the highly transmissible Omicron variant of SARS-CoV-2 had spread across most of the world. For the first time since the pandemic...

    Lauren Jelley, Nayyereh Aminisani, ... Jemma L. Geoghegan in npj Viruses
    Article Open access 03 June 2024
  12. Somatic STK11 mosaicism in a Turkish patient with Peutz-Jeghers syndrome

    Peutz-Jeghers syndrome (PJS) is an autosomal dominant disorder, caused by germline variants in the serine/threonine kinase 11 ( STK11 ) gene. However,...

    Mustafa Yilmaz, Ogun Bebek, ... Ayberk Türkyılmaz in Familial Cancer
    Article 01 June 2024
  13. DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity

    Background

    Disorder of cell cycle represents as a major driver of hepatocarcinogenesis and constitutes an attractive therapeutic target. However,...

    Yuechen Liu, Zhenkang Li, ... Zhiyong Shen in British Journal of Cancer
    Article 01 June 2024
  14. Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant

    Individuals with a germline CDKN2A pathogenic variant (PV) have a highly increased life time risk of melanoma and pancreatic cancer. This...

    A. M. Onnekink, D. C.F. Klatte, ... M. E. van Leerdam in Familial Cancer
    Article Open access 01 June 2024
  15. Prevalence of congenital anomalies and prenatal diagnosis by birth institution (public vs. non-public): indicators of inequality in access to elective termination of pregnancy for fetal anomalies

    Congenital anomalies (CA) encompass all morphological or functional alterations originating prenatally and present at birth. The prenatal diagnosis...

    Paloma Brun, Boris Groisman, ... Rosa Liascovich in Journal of Community Genetics
    Article 01 June 2024
  16. A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions

    Background

    Birt-Hogg-Dubé (BHD) syndrome is a genetic condition caused by pathogenic variants in the FLCN gene resulting in benign skin lesions,...

    Christina Shabet, Meera Kattapuram, ... Kelly B. Cha in Familial Cancer
    Article 01 June 2024
  17. The effect of mailed outreach on FIT completion among patients aged 45–50 in a safety net healthcare system

    Purpose

    Colorectal cancer screening is recommended starting at age 45, but there has been little research on strategies to promote screening in...

    Sean P. McClellan, Tanya Khan, ... Ma Somsouk in Cancer Causes & Control
    Article 01 June 2024
  18. Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer

    Background

    Recent therapeutic strategies for KRAS-mutated cancers that inhibit the MAPK pathway have attracted considerable attention. The RAF/MEK...

    Akihiro Yoshimura, Mano Horinaka, ... Toshiyuki Sakai in British Journal of Cancer
    Article 31 May 2024
  19. PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway

    Background

    Sunitinib has emerged as the primary treatment for advanced or metastatic clear cell renal cell carcinoma (ccRCC) due to its significant...

    Haibo Wang, Lijie Zhang, ... Junqi He in British Journal of Cancer
    Article 31 May 2024
  20. Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients

    Previous research on family communication of cancer genetic test results has primarily focused on non-Hispanic White patients with high-risk...

    Rachel Hodan, Miles Picus, ... Gregory E. Idos in Journal of Community Genetics
    Article 30 May 2024
Did you find what you were looking for? Share feedback.